OrthoTrophix Completes Patient Enrollment Ahead of Schedule for TPX-100 Osteoarthritis Trial OrthoTrophix, Inc. has announced the early completion of its Phase 2b trial enrollment for the TPX-100 treatment in knee osteoarthritis. This significant milestone marks a step towards innovative therapeutic options.

OrthoTrophix Completes Patient Enrollment Ahead of Schedule for TPX-100 Osteoarthritis Trial #USA #Osteoarthritis #Foster_City #OrthoTrophix #TPX-100

OrthoTrophix Launches Key Clinical Trial for TPX-100 to Treat Knee Osteoarthritis OrthoTrophix has commenced a Phase 2b clinical trial for TPX-100, aimed at treating knee osteoarthritis. This innovative approach could redefine how we view OA treatment.

OrthoTrophix Launches Key Clinical Trial for TPX-100 to Treat Knee Osteoarthritis #United_States #Foster_City #Knee_Osteoarthritis #OrthoTrophix #TPX-100